Reagents and instruments for immunology, cell biology and molecular biology.

Enoxaparin sodium [679809-58-6]

Print

Cat# T22323-100mg

Size : 100mg

Brand : TargetMol

Enoxaparin sodium

Potency:90-125 IU/mg (Anti-Xa based on dry weight)

Resource Download

COA

Enoxaparin sodium

Catalog No. T22323Cas No. 679809-58-6

Enoxaparin sodium is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment myocardial infarction (STEMI), or STEMI with subsequent percutaneous coronary intervention (PCI). It binds to and potentiates the action of antithrombin, and inhibits coagulation factors XIa, IXa, Xa and IIa (thrombin), thereby preventing formation of blood clots.

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Pack Size
1 mg
2 mg
5 mg
10 mg
25 mg
50 mg
100 mg
200 mg

Product Introduction

Bioactivity

Description

Chemical Properties

Molecular Weight	1322
Formula	C42H59N3Na4O35S2
Cas No.	679809-58-6

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Solubility Information

DMSO: Insoluble

H2O: 132.2 mg/mL (100 mM), Sonication is recommended.

Solution Preparation Table

H2O

	1mg	5mg	10mg	50mg
1 mM	0.7564 mL	3.7821 mL	7.5643 mL	37.8215 mL
5 mM	0.1513 mL	0.7564 mL	1.5129 mL	7.5643 mL
10 mM	0.0756 mL	0.3782 mL	0.7564 mL	3.7821 mL
20 mM	0.0378 mL	0.1891 mL	0.3782 mL	1.8911 mL
50 mM	0.0151 mL	0.0756 mL	0.1513 mL	0.7564 mL
100 mM	0.0076 mL	0.0378 mL	0.0756 mL	0.3782 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:

For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments

A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent

DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。

Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO TargetMol | reagent

(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.

Preparation method for in vivo formula: Take 50 μL DMSO TargetMol | reagent

main solution, add 300 μLPEG300 TargetMol | reagent

mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O TargetMol | reagent

mix well and clarify

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

traumatic brain injuryinfectioncoronavirusEnoxaparin sodiumInhibitorPK-10169ThrombininhibitSARS-CoVEnoxaparinneuroprotectiveLiver fibrosisFxaPK 10169InflammationPK10169SARS coronavirusacute coronary syndromesFactor XaLovenoxblood clotsCOVID-19Thioacetamide